D-0002-2020 Class III Terminated
FDA drug recall D-0002-2020 was initiated by Pfizer Inc. on September 12, 2019 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020. The recall status is terminated (terminated April 10, 2023). Affected quantity: 7,686 100-count bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- October 2, 2019
- Initiation Date
- September 12, 2019
- Termination Date
- April 10, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7,686 100-count bottles
Product Description
Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24
Reason for Recall
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Distribution Pattern
Nationwide in the USA
Code Information
Lot #3267079, Exp 09/2021